Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,659,838
  • Shares Outstanding, K 78,860
  • Annual Sales, $ 4,010 K
  • Annual Income, $ -214,530 K
  • EBIT $ -278 M
  • EBITDA $ -283 M
  • 60-Month Beta 0.63
  • Price/Sales 1,175.11
  • Price/Cash Flow N/A
  • Price/Book 5.59

Options Overview Details

View History
  • Implied Volatility 50.47% ( -1.20%)
  • Historical Volatility 40.15%
  • IV Percentile 7%
  • IV Rank 30.18%
  • IV High 88.58% on 03/15/24
  • IV Low 34.00% on 09/24/24
  • Put/Call Vol Ratio 1.16
  • Today's Volume 692
  • Volume Avg (30-Day) 141
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 2,158
  • Open Int (30-Day) 1,914

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.91
  • Number of Estimates 8
  • High Estimate -0.85
  • Low Estimate -0.96
  • Prior Year -1.01
  • Growth Rate Est. (year over year) +9.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.13 +19.49%
on 09/24/24
59.80 -1.84%
on 10/18/24
+5.55 (+10.44%)
since 09/20/24
3-Month
45.45 +29.15%
on 08/05/24
59.80 -1.84%
on 10/18/24
+6.04 (+11.47%)
since 07/19/24
52-Week
25.75 +127.96%
on 11/10/23
59.80 -1.84%
on 10/18/24
+29.20 (+98.98%)
since 10/20/23

Most Recent Stories

More News
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024

CRNX : 58.70 (-0.66%)
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CRNX : 58.70 (-0.66%)
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

CRNX : 58.70 (-0.66%)
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

CRNX : 58.70 (-0.66%)
Stocks Recover on Lower Bond Yields and Strength in Energy Stocks

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.56%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.26%. Stocks on Tuesday...

$SPX : 5,853.98 (-0.18%)
SPY : 583.63 (-0.16%)
$DOWI : 42,931.60 (-0.80%)
DIA : 429.37 (-0.76%)
$IUXX : 20,361.47 (+0.18%)
QQQ : 495.42 (+0.19%)
^BTCUSD : 67,637.89 (-0.11%)
ZNZ24 : 111-100 (-0.18%)
IP : 46.93 (+0.32%)
FUSN : 21.55 (+0.14%)
BKR : 36.45 (+0.14%)
APA : 25.11 (-0.20%)
International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall, Tuesday, 3/19/2024

Stocks that traded heavily or had substantial price changes on Tuesday: International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall

SMCI : 47.80 (+1.14%)
IP : 46.93 (+0.32%)
CRNX : 58.70 (-0.66%)
AZN.LN : 11,929.998 (+0.22%)
AZN : 77.44 (-1.05%)
FUSN : 21.55 (+0.14%)
FCX : 47.94 (-0.50%)
UL : 62.30 (-1.03%)
ULVR.LN : 4,790.000 (-0.87%)
Stocks Rise in Afternoon Trade

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.32%. The broader market is higher...

$SPX : 5,853.98 (-0.18%)
SPY : 583.63 (-0.16%)
$DOWI : 42,931.60 (-0.80%)
DIA : 429.37 (-0.76%)
$IUXX : 20,361.47 (+0.18%)
QQQ : 495.42 (+0.19%)
^BTCUSD : 67,637.89 (-0.11%)
ZNZ24 : 111-100 (-0.18%)
SMCI : 47.80 (+1.14%)
NVDA : 143.71 (+4.14%)
AMD : 157.90 (+1.24%)
MRVL : 81.83 (+2.48%)
Weakness in Chip Stocks Leads the Broader Market Lower

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.78%. Stocks this morning...

$SPX : 5,853.98 (-0.18%)
SPY : 583.63 (-0.16%)
$DOWI : 42,931.60 (-0.80%)
DIA : 429.37 (-0.76%)
$IUXX : 20,361.47 (+0.18%)
QQQ : 495.42 (+0.19%)
^BTCUSD : 67,637.89 (-0.11%)
ZNZ24 : 111-100 (-0.18%)
SMCI : 47.80 (+1.14%)
NVDA : 143.71 (+4.14%)
AMD : 157.90 (+1.24%)
MRVL : 81.83 (+2.48%)
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END

ONCY : 1.2600 (-6.67%)
ONC.TO : 1.76 (-4.86%)
GNLX : 2.65 (-3.64%)
CRNX : 58.70 (-0.66%)
PFE : 28.93 (-0.99%)
SGEN : 228.74 (-0.07%)
Navigating the Surge in Pancreatic Cancer: The Innovative Strategies Offering New Hope

USA News Group – Researchers are becoming increasingly concerned with the rates of cancer on the rise among people under 50. A recent study found a nearly 80% global increase in the number of under-50s...

ONCY : 1.2600 (-6.67%)
ONC.TO : 1.76 (-4.86%)
GNLX : 2.65 (-3.64%)
CRNX : 58.70 (-0.66%)
PFE : 28.93 (-0.99%)
SGEN : 228.74 (-0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly,...

See More

Key Turning Points

3rd Resistance Point 60.64
2nd Resistance Point 59.76
1st Resistance Point 59.23
Last Price 58.70
1st Support Level 57.82
2nd Support Level 56.94
3rd Support Level 56.41

See More

52-Week High 59.80
Last Price 58.70
Fibonacci 61.8% 46.79
Fibonacci 50% 42.78
Fibonacci 38.2% 38.76
52-Week Low 25.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar